CDx Diagnostics®
Roger O'Sullivan is a corporate attorney with extensive experience providing day-to-day counsel to senior management and boards of directors regarding contract negotiation, regulatory compliance, employment and intellectual property law.
Mr. O'Sullivan spent over ten years as General Counsel, Chief Privacy Officer and Corporate Secretary of a cognitive science company that commercializes cognitive tests for use in clinical trials, academic research and healthcare. He also served as Chair of the company's Security and Privacy Committee driving development and providing oversight of its HIPAA and GDPR programs.
Mr. O'Sullivan served as a community member of the Institutional Review Board of a major New Jersey healthcare system and is currently Chair of the Association of Corporate Counsel's Subcommittee on Pharmaceuticals and Research.
This person is not in any teams
This person is not in any offices
CDx Diagnostics®
The mission of CDx Diagnostics® is to provide clinicians with easily implemented, cost-effective tools to preempt cancer through enhanced detection of precancerous cellular changes. This is accomplished by a proprietary diagnostic platform that synthesizes computer imaging, artificial intelligence, molecular biology and three-dimensional cytopathology to detect precancerous change earlier and more reliably than prior methods.